News & press
Jan 15, 2025
cubeCDMS ranked #1 in ROI on G2.com
We are thrilled that cubeCDMS ranked #1 for results in the G2.com winter 2025 report!
This report reflects cubeCDMS user feedback and highlights our focus on meeting their needs and delivering exceptional return on investment (ROI).
This recognition wouldn’t have been possible without the trust and feedback from our incredible customers. Your insights inspire us to continue innovating and delivering solutions that meet your evolving needs. Thank you!
The feedback underscores our commitment to providing an innovative, efficient, and cost-effective EDC solution for CROs and sponsors. Let’s take a closer look at what makes cubeCDMS a standout choice in the market.
Exceptional ease of setup
Our solution eliminates the complexities traditionally associated with EDC systems. Its user interface, designed by data managers, results in intuitive navigation during study setup and trial execution.
At the heart of our efficiency is a robust library of over 55 eCRF templates, meticulously designed to cover a wide range of study requirements. Study teams can quickly select, customize, and deploy the forms they need without starting from scratch.
This efficiency translates directly into shorter timelines and significant cost savings.
Reducing the potential for errors
One of the standout benefits of cubeCDMS is its ability to significantly reduce errors in data capture. Our platform incorporates advanced validation logic and automated data checks directly within the eCRFs, increasing data accuracy and completeness from the start.
By catching potential discrepancies at the point of entry, cubeCDMS helps data management teams avoid the time-consuming and costly process of resolving errors later in the trial. It leads to cleaner data, fewer queries, and a smoother trial execution process – empowering teams to focus on delivering high-quality outcomes without unnecessary delays.
Affordable without compromise
Offering a breadth of functionalities is not incompatible with a budget-conscious approach. cubeCDMS is intently priced competitively, offering a cost-effective alternative without sacrificing quality or functionality.
Our customers repeatedly tell us how much they appreciate the value our solution delivers, enabling them to allocate resources more strategically across their trials.
A comprehensive platform
Beyond the boundaries of a traditional EDC system, cubeCDMS is the cornerstone of a truly unified platform designed to create efficiencies at every stage of clinical trials. From risk-based monitoring with cubeRBQM to seamless pharmacovigilance integration with cubeSAFETY, our platform offers an integrated approach to clinical trials.
When choosing cubeCDMS, sponsors and CROs embrace a suite of solutions that simplifies operations, reduces redundancies, and enhances collaboration for trial teams.
Thank you to our customers


Featured resources

The promise and challenges of the Unified Study Definition Model (USDM)
Standardization that is industry-led is unlikely to be widely successful by itself, as there is no strong incentive to adhere to them. However, when it aligns with regulatory guidelines, the chance of a timely and successful implementation is increased.